vs
Side-by-side financial comparison of BIOHARVEST SCIENCES INC. (BHST) and Genius Group Ltd (GNS). Click either name above to swap in a different company.
BIOHARVEST SCIENCES INC. is the larger business by last-quarter revenue ($8.4M vs $7.6M, roughly 1.1× Genius Group Ltd).
BioHarvest Sciences Inc. is a biotechnology firm that develops and produces sustainable, high-purity plant-derived bioactive ingredients. It serves the nutraceutical, cosmetics, and pharmaceutical sectors, leveraging proprietary cell cultivation technology to create efficacious natural products without large-scale agricultural farming.
Genius is an American digital media company founded on August 27, 2009, by Tom Lehman, Ilan Zechory, and Mahbod Moghadam. The company's eponymous website serves as a database for song lyrics, news stories, sources, poetry, and documents, in which users can provide annotations and interpretations for.
BHST vs GNS — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $8.4M | $7.6M |
| Net Profit | — | $-24.9M |
| Gross Margin | 60.3% | 31.0% |
| Operating Margin | — | -281.9% |
| Net Margin | — | -328.9% |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $-1.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $8.4M | — | ||
| Q2 25 | $8.1M | — | ||
| Q1 25 | $7.7M | $7.6M | ||
| Q3 24 | $6.5M | — | ||
| Q2 24 | $6.0M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-24.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q3 25 | 60.3% | — | ||
| Q2 25 | 60.0% | — | ||
| Q1 25 | 58.2% | 31.0% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -281.9% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -328.9% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-1.03 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $79.4M |
| Total Assets | — | $101.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $1.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $79.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $101.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-46.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-46.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
